glp 1 antidepressant Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence

GLP 1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Why are GLP 1 agonists being used to treat patients with nonalcoholic fatty liver disease? AASLD GLP 1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss Multiple target tissue effects of GLP 1 analogues on non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) ScienceDirect GLP 1 medications are changing the landscape of weight management. But there's a trade off that doesn't get enough attention, and it matters more than most people realize. Up to 40% of the weight Novo Nordisk files lawsuit against Hims & Hers for patent infringement MobiHealthNews